Social Disadvantage and Fetal Programming of Newborn-Infant Telomere Biology
新生儿端粒生物学的社会劣势和胎儿编程
基本信息
- 批准号:9105960
- 负责人:
- 金额:$ 67.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAlcohol or Other Drugs useAnimalsAttenuatedBackBehavioralBiologicalBiological MarkersBiological ProcessBiologyBirthBirth WeightCellular biologyCharacteristicsChildChild DevelopmentClassificationCohort StudiesConceptionsDataDevelopmentDietDisadvantagedDiscipline of obstetricsDiscriminationDiseaseEarly InterventionEarly identificationEndocrineEquationEthnic OriginEthnic groupExposure toFoodFunctional disorderFutureGenerationsGenomicsGenotypeGestational AgeGoalsGraphGrowthHealthHematopoieticHumanHydrocortisoneImmuneInfantInfectionInterleukin-6Interpersonal ViolenceInterventionIsoprostanesLengthLeukocytesLifeLongevityMaintenanceMaternal AgeMaternal and Child HealthMeasuresMediatingMediationMinorityMitogensModelingMothersNational Institute on AgingNewborn InfantNot Hispanic or LatinoOxidative StressPaternal AgePathway AnalysisPathway interactionsPeripheral Blood Mononuclear CellPhenotypePhysical activityPlayPopulationPregnancyProcessProtocols documentationProxyPublic HealthPublishingRaceResearchRiskRoleSkinSleepSocial supportSocietiesSocioeconomic StatusStagingStressSubgroupSystemSystems BiologyTelomeraseTestingTimeTranslational ResearchTreesValidationVariantVertical Disease TransmissionVulnerable Populationsage relatedbasebiophysical propertiesburden of illnessdisadvantaged populationdisorder riskethnic differenceethnic minority populationfeedingfetalfetal programminggestational weight gainhealth differencehealth disparityintergenerationalmanmaternal stressnoveloffspringpediatric traumapopulation healthpostnatalprenatal stressprimary outcomeprogramsprospectivepsychologicpublic health relevanceracial and ethnicracismsexsocialsocioeconomic disadvantagestudy populationtelomeretransmission process
项目摘要
DESCRIPTION (provided by applicant): Population health disparities are evident from the earliest stages of the life, persist over the life span, and are perpetuated across generations. Their most salient determinant is exposure to social disadvantage. Research has elucidated how social disadvantage gets biologically embedded to impact disease risk over the life span, but little is known about how its effects are transmitted across generations. Our application addresses this important gap. We propose to investigate the process of intergenerational (mother-to-child) transmission of social disadvantage, with a focus on newborn and infant telomere biology as the primary outcome, the intrauterine period as the transmission time window, and maternal-placental-fetal (MPF) stress biology as the proximate transmission pathway. Telomere dynamics play a fundamental, causal role in the maintenance of genomic and cellular integrity, and telomere dysfunction represents perhaps the most salient antecedent cellular phenotype of disease risk for common, age-related disorders. Animal and human studies converge to support the critical importance of the initial (early life) setting of telomere
length (TL) and telomerase activity (TA) for future health and disease risk, but little is currentl known about the determinants of this initial setting. Published and preliminary data by us and others provides biological plausibility for the novel concept that the initial setting of the telomre system is plastic and substantially influenced by developmental conditions. We hypothesize that, at the cellular level, the origins of health disparities may trace back, in part, to the effets of maternal social disadvantage on the on the initial setting of her child's telomere length and telomerase expression capacity, mediated by the "programming" actions of maternal-placental-fetal (MPF) endocrine, immune and oxidative stress biology. We propose to test this hypothesis in a prospective, longitudinal cohort study of N=1,000 child-mother dyads with serial measures across gestation and birth through the first year of life. Because race/ethnicity and socioeconomic status (SES) represent the principal proxy measures of social disadvantage, and because racial/ethnic differences in health are most pronounced between Non-Hispanic Blacks (hereinafter `Black') and Non-Hispanic Whites (hereinafter `White'), our proposed study population will include approximately equal numbers of Black and White mothers and their offspring. A unique strength of this population is the substantial variation in SES not only across
but also within the two racial/ethnic groups, which will enable us to extricate their independent and combined (interaction) effects. We also will evaluate whether effects vary by the sex of the child. Specific Aims: A1: To test the hypothesis that maternal social disadvantage is prospectively associated with newborn and infant telomere biology. A2: To test the hypothesis that maternal-placental-fetal (MPF) stress biology mediates the effects of social disadvantage on newborn and infant telomere biology. A3: Identify and quantify the maternal psychological, behavioral and biophysical characteristics that are associated with social disadvantage and may account for its impact on newborn and infant telomere biology. The significance and impact of this study derives from the importance of better understanding the determinants and mechanisms underlying age-related disease risk in minority, disadvantaged populations (NIA Reversibility Initiative 2012) to inform translational research on early identification and intervention.
描述(由申请人提供):人口健康差异从生命的最初阶段就很明显,在整个生命周期中持续存在,并且在几代人之间持续存在。他们最显着的决定因素是处于社会劣势。研究已经阐明了社会劣势如何在生物学上嵌入并影响一生中的疾病风险,但对其影响如何跨代传播却知之甚少。我们的应用程序解决了这一重要差距。我们建议研究社会劣势的代际(母婴)传播过程,重点关注新生儿和婴儿端粒生物学作为主要结果,宫内期作为传播时间窗口,母体-胎盘-胎儿(MPF)应激生物学作为最近传播途径。端粒动力学在维持基因组和细胞完整性中发挥着基本的因果作用,端粒功能障碍可能代表了常见的年龄相关疾病风险的最显着的先行细胞表型。动物和人类研究一致支持端粒初始(生命早期)设置的至关重要性
长度(TL)和端粒酶活性(TA)对未来健康和疾病风险的影响,但目前对这一初始设置的决定因素知之甚少。我们和其他人发表的初步数据为端粒系统的初始设置是可塑的并且很大程度上受发育条件影响的新概念提供了生物学合理性。我们假设,在细胞水平上,健康差异的根源可能部分追溯到母亲的社会劣势对其孩子端粒长度和端粒酶表达能力初始设定的影响,这是由母体-胎盘-胎儿(MPF)内分泌、免疫和氧化应激生物学的“编程”作用介导的。我们建议通过一项前瞻性纵向队列研究来检验这一假设,该研究对 N=1,000 名儿童-母亲二人组进行了从妊娠到出生直至生命第一年的一系列测量。由于种族/族裔和社会经济地位(SES)代表了社会劣势的主要代理指标,并且由于健康方面的种族/族裔差异在非西班牙裔黑人(以下简称“黑人”)和非西班牙裔白人(以下简称“白人”)之间最为明显,因此我们提议的研究人群将包括数量大致相等的黑人和白人母亲及其后代。该人群的独特优势在于社会经济地位的巨大差异,不仅在不同地区
而且还存在于两个种族/族裔群体之内,这将使我们能够摆脱它们的独立和组合(相互作用)影响。我们还将评估影响是否因孩子的性别而异。具体目标: A1:检验母亲的社会劣势与新生儿和婴儿端粒生物学前瞻性相关的假设。 A2:检验母体-胎盘-胎儿(MPF)应激生物学介导社会劣势对新生儿和婴儿端粒生物学的影响的假设。 A3:识别并量化与社会劣势相关的母亲心理、行为和生物物理特征,并可能解释其对新生儿和婴儿端粒生物学的影响。这项研究的意义和影响源于更好地了解少数弱势群体中年龄相关疾病风险的决定因素和机制的重要性(NIA Reversibility Initiative 2012),为早期识别和干预的转化研究提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH H BLACKBURN其他文献
ELIZABETH H BLACKBURN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH H BLACKBURN', 18)}}的其他基金
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
炎症、衰老、微生物和阻塞性肺病 (I AM OLD) 研究
- 批准号:
9257199 - 财政年份:2015
- 资助金额:
$ 67.24万 - 项目类别:
Cancer cell telomere dynamics and responses to perturbations
癌细胞端粒动力学和对扰动的反应
- 批准号:
7913694 - 财政年份:2009
- 资助金额:
$ 67.24万 - 项目类别:
TELOMERASE ASSOCIATED FACTORS AND THEIR ROLES IN CANCER PROGRESSION
端粒酶相关因子及其在癌症进展中的作用
- 批准号:
7724195 - 财政年份:2008
- 资助金额:
$ 67.24万 - 项目类别:
TELOMERASE ASSOCIATED FACTORS AND THEIR ROLES IN CANCER PROGRESSION
端粒酶相关因子及其在癌症进展中的作用
- 批准号:
7601841 - 财政年份:2007
- 资助金额:
$ 67.24万 - 项目类别:
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction
基于端粒酶功能障碍的乳腺癌治疗剂
- 批准号:
7384761 - 财政年份:2007
- 资助金额:
$ 67.24万 - 项目类别:
TELOMERASE ASSOCIATED FACTORS AND THEIR ROLES IN CANCER PROGRESSION
端粒酶相关因子及其在癌症进展中的作用
- 批准号:
7369084 - 财政年份:2006
- 资助金额:
$ 67.24万 - 项目类别:
TELOMERASE ASSOCIATED FACTORS AND THEIR ROLES IN CANCER PROGRESSION
端粒酶相关因子及其在癌症进展中的作用
- 批准号:
7180999 - 财政年份:2005
- 资助金额:
$ 67.24万 - 项目类别:
Responses to perturbing telomeres in human cells
对人类细胞中端粒扰动的反应
- 批准号:
6782655 - 财政年份:2002
- 资助金额:
$ 67.24万 - 项目类别:
Cancer cell telomere dynamics and responses to perturbations
癌细胞端粒动力学和对扰动的反应
- 批准号:
8114109 - 财政年份:2002
- 资助金额:
$ 67.24万 - 项目类别:
Cancer cell telomere dynamics and responses to perturbations
癌细胞端粒动力学和对扰动的反应
- 批准号:
7901675 - 财政年份:2002
- 资助金额:
$ 67.24万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 67.24万 - 项目类别:
Research Grant














{{item.name}}会员




